Eline Menu

17PUBLICATIONS
27CO-AUTHORS
Molecular targetsGene and molecular therapyMedical infection agents (incl. prions)Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 11, 2025
PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism.

Inge Oudaert, Lauren van den Broecke, Osman Aksoy

|Aug 20, 2025
Syntenin inhibition impairs stroma-tumor communication in multiple myeloma and improves bortezomib treatment efficiency.

Chenggong Tu, Raphael Leblanc, Arne Van der Vreken

|Dec 18, 2023
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.

Rong Fan, Hatice Satilmis, Niels Vandewalle

|Sep 27, 2023
Hypoxic Bone Marrow Stromal Cells Secrete miR-140-5p and miR-28-3p That Target SPRED1 to Confer Drug Resistance in Multiple Myeloma.

Hui Zhang, Zhimin Du, Chenggong Tu

|Feb 22, 2023
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis.

Arne Van der Vreken, Inge Oudaert, Gamze Ates

|Oct 17, 2022
Targeting the β2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism.

Hatice Satilmis, Emma Verheye, Philip Vlummens

Pageof 3

Frequent Collaborators

7 joint publications

Elke De Bruyne

4 joint publications

Ken Maes

4 joint publications

Kim De Veirman

2 joint publications

Inge Oudaert